Samuel Cytryn, MD

DocwireNews

<p>Sam Cytryn, MD, of Memorial Sloan Kettering Cancer Center, discusses the impact of the October 2024 FDA approval of zolbetuximab for first-line treatment of advanced gastric and gastroesophageal junction adenocarcinomas, emphasizing its role in a personalized approach to care. According to Dr. Cytryn, zolbetuximab addresses key gaps in treatment by targeting claudin 18.2, particularly in PD-L1-negative or low-expressing tumors. Dr. Cytryn highlights the practical challenges of integrating claudin testing and managing unique gastrointestinal side effects, while balancing the drug’s benefits, including improved progression-free and overall survival. Looking ahead, he explores the future of claudin-targeted therapies, combination regimens with immunotherapy, and the broader implications of this first-in-class therapy in advancing precision oncology.</p>


Stephen V. Liu, MD

Cecilia Brown

Stephen Liu, MD, Weighs in on MARIPOSA Overall Survival Data

EGFR+ NSCLC

Team Develops Model to Enhance Prediction of KRAS Mutations in Patients With NSCLC

KRAS+ NSCLC

Amit Goyal, MD

DCB-BIF Trial Results Favor Use of Drug-Coated Balloons to Rescue Jeopardized Side-branches After Provisional Bifurcation Stenting

Interventional Cardiology

Latest News

Impact of Zolbetuximab on Gastric Cancer Treatment

Gastric Cancer

Dr. Cytryn provides insights on the FDA approval of zolbetuximab and how it will impact clinical practice. 

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe